Shows
Data in BiotechHow Twist Bioscience Synthesizes 32 Million DNA Sequences a Day for AI Drug DiscoveryAI can design a molecule in seconds, however someone still has to build it and test it before it means anything.
You're pouring resources into AI-driven molecule design, but nobody on your team has answered the harder question: can you actually make what the model just designed?
Patrick Finn is President and Chief Operating Officer of Twist Bioscience, a company writing DNA on silicon chips at a scale of roughly 32 million distinct oligonucleotides a day. Under his leadership, Twist has become the manufacturing layer behind antibody discovery, liquid biopsy, and molecular residual disease testing programs...
2026-10-1446 minData in BiotechHow Standardized Cell Labeling Could Fix Biotech's Data ProblemFlow cytometry can find a cell population in seconds, but naming it consistently across labs is a problem still unsolved.
If you've ever tried to compare cytometry data across studies, CROs, or even two scientists in the same lab, you know the frustration: everyone gates their own way, and the same cell population ends up with three different definitions. That inconsistency is quietly limiting what AI can do with biotech data.
Ryan Brinkman is VP Research Director of Flow Cytometry Bioinformatics at Dotmatics and Founding Director of SOULCAP, the Standard Ontology for Unambiguous Labeling in...
2026-09-301h 13Data in BiotechDrugBank CEO: Why Your AI Model Is Only Giving You Half the AnswerAsk a general AI model how many approved drugs hit a target, and it might tell you three when the real answer is six, sounding just as confident either way.
If your team is grounding drug discovery decisions in AI output with no way to trace where the answer came from, you're one regulator's question away from a very expensive problem.
Lisa Downey is CEO of DrugBank, a structured biomedical intelligence platform cited in more than 60,000 papers and used by nine of the top 20 global pharma companies. She previously built Clarivate's genomic and rare disease...
2026-09-1752 minData in BiotechHow to Identify the Blind Spots in Your Biotech's Genomic Data Before They Cost You a Drug TargetMost drug discovery genomic data comes from a thin slice of the world, and that bias follows every decision downstream.
Your team can run a Mendelian randomization study on 35,000 patients and still walk away with a single signal that doesn't even apply to the population you care about. If your phenotype definitions are fuzzy, more data won't save you.
Erika Kvikstad is a computational biologist who led precision medicine for cardiovascular disease at Bristol-Myers Squibb, working on therapies including Camzyos for hypertrophic cardiomyopathy. She now works independently on genomic data equity, focused on how reference...
2026-09-021h 10Data in BiotechHow to Turn Single-Cell Data Into a New Class of Cell-Depleting TherapiesWhy treating the cell, not the protein, could turn chronic disease treatment into something closer to a cure.
You've built single-cell pipelines that spit out clusters, p-values and target lists, but nothing that survives contact with the clinic. What if the clustering method itself is quietly leading you astray?
Adam Freund is Founder and CEO of Arda Therapeutics, a biotech using single-cell sequencing to find the pathogenic cells driving chronic disease. He spent seven years as a Principal Investigator at Calico Life Sciences, building a research lab on the biology of ageing and helping grow...
2026-08-1954 minData in BiotechWhy Biotech Talks About AI But Won't Pay for the Data It NeedsEveryone in biotech agrees AI needs more data. Almost no one is willing to pay for it.
If you're trying to build or buy a biotech AI model, you've hit the same wall: predictive performance depends on data your budget doesn't cover, and nobody in the field seems willing to close that gap.
John Androsavich runs Ginkgo Datapoints, the bio AI data arm of Ginkgo Bioworks. He trained as an RNA scientist, spent years on the pharma side deciding which technologies were worth buying, and now sells the raw biological data everyone claims to want.
2026-08-051h 02Data in BiotechBeyond Language: Why Drug Discovery Needs Physical AI, Not Just Large Language ModelsIn this episode of Data in Biotech, host Ross Katz sits down with Woody Sherman, Founder and Chief Innovation Officer at PsiThera, for a conversation on why AI can transform drug discovery's paperwork and code while barely touching the hardest part of the problem: the molecules themselves. Woody's career runs through physical chemistry at MIT; over a decade at Schrödinger building tools the industry still relies on; founding Silicon Therapeutics (where his team took a small molecule STING agonist from concept to clinic in roughly three years); scaling that platform after Roivant's acquisition; and now leading PsiThera's effort t...
2026-07-2058 minData in BiotechSynthesizable by Design: Rethinking AI's Role in Small Molecule Drug DiscoveryIn this episode of Data in Biotech, host Ross Katz sits down with Paul Finn, Chief Scientific Officer at Oxford Drug Design, for a conversation on what it actually takes to find a drug molecule that works not just on paper but also in the lab, in the cell, and, ultimately, in the clinic. Paul brings four decades of experience across what became GSK, Pfizer, and a series of Oxford-area spinouts and has shepherded a compound all the way to a marketed drug. That perspective gives him a particular kind of skepticism toward AI results that look too good...
2026-06-1759 minData in BiotechFrom Tissue to Mechanism to Decision: Building AI for Computational OncologyIn this episode of Data in Biotech, host Ross Katz sits down with Arvind Rao, Professor of Computational Medicine and Bioinformatics at the University of Michigan, for a discussion on the gap between what biomedical AI can do and what it can reliably be trusted to do in clinical practice. Arvind's research sits at the intersection of computational oncology and AI governance and his lab works across H&E histopathology, multiplex immunofluorescence, spatial transcriptomics, and single-cell RNA sequencing, not just to build predictive models, but to understand the full lifecycle from data to model to inference, and to ask...
2026-06-0246 minData in BiotechCavities in the Data: Building FDA-Cleared AI for Dental Imaging with OverjetIn this episode of Data in Biotech, host Ross Katz sits down with Sadegh Salehi, Director of Research and Principal Scientist at Overjet, to explore what rigorous model evaluation actually looks like when the stakes are clinical.
Overjet builds FDA-cleared vision models that detect and quantify dental disease across billions of X-ray images from thousands of practices - a data problem with a staggering number of dimensions. Thirty-two teeth per adult patient, each with different morphology. Multiple image types capturing different anatomy. Fifteen to twenty sensor manufacturers producing perceptually distinct images, each with different contrast, resolution, and n...
2026-05-1358 minData in BiotechData as a Moat: Why Biotech's Most Valuable Asset is Buried in a Hard DriveIn this episode of Data in Biotech, host Ross Katz sits down with Jesse Johnson, founder of Merelogic, a software consulting firm specializing in data infrastructure for biotech organizations.
Jesse brings a rare perspective to the conversation: having built data systems at Google where engineers control the data collection function end to end, before moving into biotech, where the biology does what it wants and bench scientists, not engineers, generate the data.
The result is a grounded, pragmatic take on one of the most consequential and underappreciated questions in life sciences right now: as bio fo...
2026-04-3042 minData in BiotechMarkus Gershater on Why Experimental Design in Biotech is Broken and How to Fix ItThis week, we're delighted to be joined by Markus Gershater, Chief Scientific Officer and CoFounder of Synthace - a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress.
Host Ross Katz speaks with Markus on what’s broken about:
What’s broken about how laboratories across the globe run biological experiments at scaleThe opportunity that exists for researchers in striving to achieve experimental design automation processesWhy, as an industry, we must move towards implementing infrastructure that enables multifactorial experiments versus one-factor experimentsAnd the role of...
2026-04-1541 minData in BiotechData Science and Diagnostic Models - the What, Why and How with Michelle WiestThis week, we're delighted to be joined by Michelle Wiest, Director of IVD Biostatistics at Freenome - a high-growth biotech company that creates tools to help prevent, detect, and treat disease.
Host Ross Katz speaks with Michelle on the use of biostatistics in the field of diagnostics, what biases can corrupt diagnostic tests and how to catch them early, the different types of data sets that are being used to develop diagnostic models and how to prepare to present data to regulatory bodies such as the FDA.
---
If you’re a biotech co...
2026-04-1544 minData in BiotechThe Patient is Not a Document: Foundation Models for Biomedical AI with Standard BioModelIn this episode of Data in Biotech, host Ross Katz sits down with Kevin Brown, co-founder of Standard BioModel, to explore one of the most ambitious projects in biomedical AI, building a multimodal foundation model that represents the full complexity of a patient across time.
Drawing on a career spanning brain-computer interfaces, computer-aided diagnosis at Siemens Healthineers, and oncology data science at Bristol Myers Squibb, Kevin shares the scientific and philosophical journey that led him to a single conviction: a patient is not a document. Rather than reducing a patient to clinical notes, ICD-10 codes, or isolated t...
2026-04-1549 minData in BiotechPhysics, Free Energy, & Drug Discovery: Inside Schrödinger's Computational PlatformIn this episode of Data in Biotech, Ross Katz sits down with Robert Abel, Chief Scientific Officer of the Platform at Schrödinger, to explore how physics-based computational modeling is transforming drug discovery.
Robert unpacks why machine learning alone isn't enough to navigate the vast complexity of chemical space - an estimated at 10⁶⁰ possible drug-like molecules - and how integrating atomistic simulations with ML creates a more accurate, reliable, and scalable approach to identifying viable drug candidates. From free energy perturbation calculations to generative AI, Robert offers a rare inside look at how Schrödinger's technology platform is acce...
2026-04-0157 minData in BiotechAI in biotech: separating hype from reality with Ben LocwinIn this episode of Data in Biotech, host Ross Katz sits down with Ben Locwin, Vice President at Reliant Life Sciences, to explore the evolving landscape of artificial intelligence in biotechnology.
Join us as we discuss why nearly every biotech claims to use AI but few actually do, examine successful applications like AlphaFold, and explore the challenges of implementing AI across drug development, manufacturing, and regulatory processes. Ben shares insights on maintaining healthy skepticism, understanding data provenance, and looking ahead to what this year may bring for AI in life sciences.
What you’ll lea...
2026-03-1130 minData in Biotech3D Printing Therapeutics at Scale with Aprecia PharmaceuticalsIn this episode of Data in Biotech, Ross Katz sits down with Kyle Smith and Jacob Mayer from Aprecia Pharmaceuticals to explore how 3D printing is transforming pharmaceutical manufacturing. They dive into the unique binder jetting process, in-cavity printing, and how real-time data and automation are enabling agile, scalable, and precise drug production. Discover how Aprecia's approach is changing the game for clinical trials and personalized medicine.
What you'll learn in this episode:
>> How Aprecia developed the world’s first FDA-approved 3D printed drug
>> Why binder jetting stands out am...
2026-02-2549 minData in BiotechSuccess-Driven Drug Discovery with OpenBench CEO James YoderIn this episode of Data in Biotech, host Ross Katz sits down with James Yoder, Founder and CEO of OpenBench, to unpack a radical new approach to early-stage drug discovery. James shares how OpenBench's "success-driven" model shifts risk away from biotech partners by only charging for validated hits. They dive deep into computational screening, molecular modeling, and the company's evolving tech stack that's making hit discovery smarter and more accessible. Discover how data, AI, and strategic collaboration are redefining biotech R&D.
What you'll learn in this episode:
>> Why OpenBench moved...
2026-02-1153 minData in BiotechBrant Peterson on Valo Health’s patient-first approach to drug discoveryBrant Peterson, Vice President & Fellow at Valo Health, joins Data in Biotech to explore how his team leverages real-world data, genetic insights, and machine learning to de-risk drug discovery. From building causal DAGs to identifying patient subtypes in neurodegenerative diseases like Parkinson’s, this episode dives deep into a patient-first, data-driven approach to biomedical innovation.
What You'll Learn in This Episode:
>> How Valo Health uses real-world evidence and EHR data to prioritize drug targets earlier in the development pipeline.
>> Why integrating wet lab experiments and causal DAGs accelerates therapeutic validation.
...
2026-01-2952 minData in BiotechInside Dash Bio’s productized CRO model with Ander TalletAnder Tallet, co-founder and COO of Dash Bio and CEO of DigitalRadius, joins Ross Katz to discuss transforming the traditional CRO model through automation, transparency, and productization. Drawing on deep experience from Moderna, Science Exchange, and his leadership roles in digital transformation, Ander shares how Dash Bio is slashing turnaround times, improving data quality, and simplifying procurement for biotech companies. This episode unpacks the future of CRO services, strategic procurement, and the power of operational innovation in biotech.
What you'll learn in this episode:
>> Why traditional CRO models hinder speed and transparency in...
2026-01-1443 minData in BiotechFrom discovery to delivery: AI’s impact on nanomedicineIn this episode of Data in Biotech, Ross Katz chats with Mitra Mosharraf, Chief Scientific Officer at HTD Biosystems, about how AI and machine learning are revolutionizing nanomedicine. They explore the use of AI in drug discovery, formulation, manufacturing, and clinical development, highlighting how data-driven strategies are improving safety, reducing costs, and enabling more personalized therapies in the biotech space.
What you'll learn in this episode:
>> How AI and ML reduce costs and increase success rates in nanomedicine development.
>> Key challenges in nano drug delivery and how machine learning helps overcome...
2025-12-3146 minData in BiotechJaidev Chakka on building the future of bioprinted medicineIn this episode of Data in Biotech, Ross Katz chats with Jaidev Chakka, Principal Scientist at the University of Mississippi School of Pharmacy, about how 3D bioprinting and AI are reshaping pharmaceutical manufacturing. They explore the development of custom scaffolds for tissue engineering, the integration of gene delivery systems, and how data-driven approaches are enabling smarter, more scalable solutions in personalized medicine.
What you'll learn in this episode:
>> How 3D printing is enabling customized bone scaffolds and regenerative therapies
>> The role of AI in optimizing pharmaceutical 3D printing parameters
>>...
2025-12-2645 minData in BiotechFrom screening to IND: How Veloxity accelerates critical drug decisionsIn this episode of Data in Biotech, Ross Katz sits down with Callie Celichowski and Isa Kupke from Veloxity Labs to discuss how their CRO leverages speed, precision, and innovation to support drug development. Learn how they use mass spectrometry, cloud-based infrastructure, and hands-on client partnerships to drive rapid, high-quality bioanalytical insights that support everything from preclinical studies to FDA submissions.
What you'll learn in this episode:
>> Why "speed with purpose" is essential for bioanalytical CROs supporting biotech and pharma clients
>> The benefits and challenges of working with peptides...
2025-12-2225 minData in BiotechRevolutionizing bioanalysis with high-resolution mass specIn this episode of Data in Biotech, host Ross Katz sits down with Eshani Galermo, Staff Scientist at SCIEX, to explore the next generation of mass spectrometry in pharma and biopharma. Eshani explains how innovations like the ZenoTOF 8600 are redefining sensitivity, selectivity, and workflow efficiency in bioanalytical chemistry. Discover how high-resolution accurate mass (HRAM) systems are unlocking new capabilities in drug discovery, clinical studies, and regulatory science.
What you'll learn in this episode:
>> Why traditional mass spectrometry falls short in modern bioanalysis
>> How the ZenoTOF 8600 enhances sensitivity and reduces sample volume...
2025-12-1532 minData in BiotechMastering solubility and stability in drug development with Serán BioScienceIn this episode of Data in Biotech, Ross Katz chats with Wesley Tatum, Principal Engineer at Serán BioScience, about the intricacies of formulating low-solubility drug products. They explore the science behind amorphous solid dispersions, how data informs formulation choices, and why balancing performance, manufacturability, and stability is critical in modern drug development.
What you'll learn in this episode:
>> How amorphous solid dispersions improve solubility and stability in drug products
>> Why formulation decisions hinge on early data collection and modeling
>> The role of data infrastructure in formulation R&D a...
2025-12-0351 minData in BiotechApplying ML/AI to Drug Development with Anil KaneDr. Anil Kane, Global Head of Technical & Scientific Affairs at Thermo Fisher Scientific, joins Ross Katz to discuss how AI, machine learning, and digital tools are reshaping drug development. From predictive modeling for formulation to digital manufacturing efficiencies, discover how data-driven approaches are reducing time, cost, and complexity in pharma innovation.
What You'll Learn in This Episode:
>> How predictive modeling eliminates trial-and-error in drug formulation
>> The role of AI/ML in improving manufacturing efficiency and reducing downtime
>> How Thermo Fisher’s ASAP program accelerates stability testing
>> The fu...
2025-11-2635 minData in BiotechStreamlining bioanalytical workflows with Watson LIMS and Thermo FisherIn this episode of Data in Biotech, host Ross Katz sits down with John Liberty, Senior Bioanalysis Technical Sales Consultant at Thermo Fisher Scientific. They dive deep into how Watson LIMS™ supports regulated bioanalysis workflows, the evolving role of lab automation, and how Connect Enterprise aims to unify biotech digital ecosystems.
What you'll learn in this episode:
>> Why Watson LIMS is purpose-built for bioanalysis and how it enhances compliance and data traceability.
>> The role of lab automation in boosting productivity and reducing manual tasks.
>> How Connect Enterprise integrates lab sy...
2025-11-2049 minData in BiotechScaling AI infra in biotech with Saturn Cloud and NebiusDiscover how biotech and healthcare teams are fast-tracking research and development through AI and high-performance cloud infrastructure. Ross Katz sits down with Hugo Shi of Saturn Cloud and Ilya Burkov of Nebius to explore scalable, secure solutions for GPU-heavy AI workloads. From compliance to cost savings, this episode unpacks what it takes to innovate at scale in life sciences.
What You'll Learn in This Episode:
>> Why AI workloads in biotech demand specialized infrastructure
>> How Saturn Cloud and Nebius simplify compliance, scale, and security for life sciences
>> Real-world examples of...
2025-11-0552 minData in BiotechThe Future of Co-Folding and Federated Learning with ApherisRobin Rohm, CEO and Co-Founder of Apheris, joins Ross Katz to explore how federated learning is unlocking secure, cross-company collaboration in pharma. Discover how Apheris is enabling biopharma leaders to train cutting-edge co-folding models without sharing sensitive data, why AlphaFold 3 wasn’t enough, and what OpenFold 3 means for the future of AI in drug discovery.
What You'll Learn in This Episode
>> Why federated learning is a game-changer for pharma data sharing and AI-driven research
>> How OpenFold 3 builds on AlphaFold’s legacy to solve the protein-ligand interaction challenge
>> The role of struc...
2025-10-2249 minData in BiotechAutomating biopharma knowledge work with ConvokeWhat if biotech teams could automate the most information-intensive parts of bringing a drug to market? In this episode of Data in Biotech, host Ross Katz speaks with Convoke co-founders Alex Telford and Maged Ahmed about building an AI-native knowledge acquisition and curation system for biopharma. Learn how they're transforming clinical research, regulatory writing, and competitive intelligence using LLMs, semantic search, and scalable data infrastructure.
What You'll Learn in This Episode:
>> How Convoke unifies public and private biotech data into a single workspace for smarter decision-making
>> Why structured outputs and semantic laye...
2025-10-0156 minData in BiotechHow Eli Lilly’s new platform TuneLab codevelops AI models with biotechDr. Aliza Apple, VP of Catalyze360 AI/ML at Eli Lilly, joins Ross Katz to unveil TuneLab—a first-of-its-kind federated learning platform accelerating preclinical drug discovery. Learn how Lilly’s billion-dollar models are empowering early-stage biotechs, the science behind federated learning, and what this means for the future of pharmaceutical R&D.
What You'll Learn in This Episode:
>> How Eli Lilly's TuneLab democratizes access to proprietary AI models trained on decades of pharmaceutical data
>> What federated learning means for IP protection and collaborative data sharing in biotech
>> Which two key use...
2025-09-1740 minData in BiotechInside Merck's Computational Biology Approach with Jesper RygeIn this episode of Data in Biotech, host Ross Katz talks with Jesper Ryge, Director of Computational Biology at Merck Germany. Jesper shares his journey from neuroscience labs to leading computational teams, offering deep insights into disease modeling, target discovery, and multi-omics integration. Discover how AI and spatial transcriptomics are shaping the future of pharma R&D.
What You'll Learn in This Episode
>> How single-cell and spatial transcriptomics enhance disease mechanism discovery
>> Why data integration and knowledge graphs are critical for target validation
>> How computational biology teams interface with wet...
2025-09-0346 minData in BiotechWhere Biotech Innovation Really Happens: 50th Episode Special with Wolfgang Halter, Jacob Oppenheim, and Dave JohnsonTo mark our 50th episode, host Ross Katz brings back three visionary leaders—Dave Johnson (Dash Bio), Wolfgang Halter (Merck Life Science), and Jacob Oppenheim (RAVen)—together for a reflection on the evolution of biotech. They unpack the realities behind AI hype, the future of data-driven innovation, and what’s really changing in drug development.
What You'll Learn in This Episode:
>> Where real innovation is emerging across startups, big tech, and academia
>> The biggest misconceptions about data in biotech—and why they persist
>> What it takes to build trust...
2025-08-2031 minData in BiotechHow BioRaptor is Modernizing Bioprocessing WorkflowsIn this episode of Data in Biotech, Yaron David, CTO and Co-Founder of BioRaptor, joins host Ross Katz to explore how biotech companies can gain a holistic view of bioprocessing through real-time data integration, visualization, and modeling. Learn how BioRaptor’s full-stack platform helps scientists replace clunky spreadsheets with actionable insights—accelerating experiments and optimizing yields.
What You'll Learn in This Episode:
>> Why Excel is holding back innovation in bioprocessing labs
>> How BioRaptor enables holistic bioprocess understanding across experiments
>> The role of virtual sensors in enhancing real-time data visibility
>>...
2025-07-3149 minData in BiotechModernizing Clinical Data Analysis with Jesse PaquetteIn this episode of Data in Biotech, Jesse Paquette, co-founder and Chief Science Officer of Tag.bio, joins Ross Katz to explore how data mesh architecture and FAIR data principles are transforming clinical and research workflows in life sciences. From harmonizing legacy systems to enabling AI-readiness, Jesse shares how Tag.bio empowers domain experts to make data-driven decisions faster and more effectively.
What You'll Learn in This Episode:
>> How Tag.bio leverages data mesh and FAIR principles to democratize biomedical data access.
>> The challenges biotech firms face with legacy infrastructure and clin...
2025-07-1145 minData in BiotechBuilding Scalable Data Platforms for Spatial Biology with Kenny Workman of LatchBioIn this episode of Data in Biotech, Ross Katz sits down with Kenny Workman, co-founder and CTO of LatchBio, to unpack how biotech’s data infrastructure must evolve to meet the demands of next-gen assays. From scalable workflows to high-performance visualization tools, Kenny breaks down the shift from traditional biotech to a future defined by data-driven research and agile cloud platforms.
What You'll Learn in This Episode:
Why spatial biology and high-throughput assays require new data infrastructure strategiesHow LatchBio’s five core components streamline molecular data processingThe challenges of selling into biotech vs. solution provider...
2025-06-2555 minData in BiotechSolving Chronic Disease with Life Insurance and Data Featuring Jeremy ShaneEntrepreneur Jeremy Shane joins host Ross Katz to discuss Life for Health, a revolutionary framework aiming to tackle chronic disease through the integration of life insurance, longitudinal data, and preventative care.
From drug discovery feedback loops to outcomes-based pricing, Shane outlines a bold new path for biotech and healthcare convergence.
What You'll Learn in This Episode:
Why today's healthcare system fails chronic disease patients and how Life for Health aims to fix it.How longitudinal data and life insurance can realign healthcare incentives for better outcomes.The economic logic behind outcomes-based annuity prici...
2025-06-111h 00Data in BiotechHow Etiome Is Redefining Preemptive Medicine with Scott LipnickIn this episode of Data in Biotech, host Ross Katz sits down with Scott Lipnick, Co-Founder and President of Etiome, to explore how preemptive medicine is changing the way biotech approaches therapeutic modeling and intervention.
Discover how Etiome’s recently launched, AI-driven platform is built to detect disease earlier, identify precise biomarkers, and create stage-specific treatments—all before symptoms arise.
It’s a visionary approach to healthcare focused on preserving health, not just managing illness.
What You'll Learn in This Episode:
Why Scott Lipnick believes the future of medicine lies in preem...
2025-05-2958 minData in BiotechTransforming Houseplants with Synthetic Biology with Patrick TorbeyIn this episode of Data in Biotech, host Ross Katz speaks with Patrick Torbey, CEO and Co-Founder of Neoplants, about using genetic engineering and microbiome innovation to tackle indoor air pollution. Patrick explains how Neoplants is turning everyday houseplants into powerful air purifiers using synthetic biology, offering insights into VOC degradation, enzyme pathways, and data-driven R&D.
What You'll Learn in This Episode:
How genetically modified plants and microbiomes can reduce indoor air pollution by targeting VOCs like formaldehyde and benzeneThe scientific and engineering challenges of modifying indoor plants at the genomic levelWhy data-driven test...
2025-05-1447 minData in BiotechTransforming Houseplants with Synthetic Biology with Patrick TorbeyIn this episode of Data in Biotech, host Ross Katz speaks with Patrick Torbey, CEO and Co-Founder of Neoplants, about using genetic engineering and microbiome innovation to tackle indoor air pollution. Patrick explains how Neoplants is turning everyday houseplants into powerful air purifiers using synthetic biology, offering insights into VOC degradation, enzyme pathways, and data-driven R&D.
What You'll Learn in This Episode:
How genetically modified plants and microbiomes can reduce indoor air pollution by targeting VOCs like formaldehyde and benzeneThe scientific and engineering challenges of modifying indoor plants at the genomic levelWhy data-driven test...
2025-05-141h 06Data in BiotechHow Phage Therapy is Scaling to Meet Antibiotic Resistance with Jessica SacherPhage therapy is stepping into the spotlight as antibiotic resistance rises - and Jessica Sacher is helping lead the charge. In this episode, Ross Katz speaks with Jessica, Co-Founder of Phage Directory and Staff Scientist at Stanford, about sourcing phages, operationalizing therapy, and predicting efficacy through data. This conversation explores how personalized phage therapy works, its scalability, and the data challenges shaping its future.
What You'll Learn in This Episode:
Why phage therapy is a promising solution to antibiotic-resistant infectionsHow Phage Directory connects researchers and clinicians to accelerate treatmentWhat operational hurdles exist in scaling pers...
2025-04-3059 minData in BiotechTargeting Transcription Factors with AI, featuring Will Fondrie from Talus BioHow do you drug the undruggable? In this episode of Data in Biotech, Ross Katz sits down with Will Fondrie, Head of Data Science and Engineering at Talus Bio, to explore how machine learning, mass spectrometry, and innovative computational models are transforming drug discovery. Learn how Talus Bio is targeting transcription factors—once considered out of reach—with scalable, high-impact data science.
What You'll Learn in This Episode
Why transcription factors are historically hard to drug and how Talus Bio is changing thatHow mass spectrometry offers high-throughput, unbiased views of protein-DNA interactionsThe role of reco...
2025-04-1646 minData in BiotechDecoding the Dark Proteome: Biological Insights for Pharma with Dr. Jonathan Usuka from SapientIn this episode of the Data and Biotech Podcast, host Ross Katz sits down with Dr. Jonathan Usuka to discuss Usuka’s extensive background in bioinformatics and genomics, leading to his current role as CEO of Sapient.
The conversation dives into the importance of deep molecular characterization of diseases, the role of proteomics and metabolomics in drug discovery, and the gaps between real-world data and clinical trial data.
As a leader with a small but impactful team, Jonathan discusses the complexities of the dark proteome and metabolites, emphasizing the opportunity for deeper biological insights in phar...
2025-04-0246 minData in BiotechHow AI Can Increase Clinical Trial Efficiency with Patrick Leung from Faro HealthHow can AI improve clinical trials and accelerate drug development?
In this episode of Data in Biotech, Ross Katz sits down with Patrick Leung, CTO of Faro Health, to explore how AI-driven tools are reshaping clinical trial design. Patrick shares insights into document generation, patient burden analysis, and AI governance in biotech.
Learn how Faro Health is developing clinical protocols and leveraging AI to optimize trial success while ensuring regulatory compliance. Whether you're in biotech or healthcare, this conversation offers valuable takeaways on the future of AI in increasing clinical trial efficiency.
What You...
2025-03-1939 minData in BiotechOrganoids and Active Learning for Chronic Disease with Naren TallapragadaIn this episode of Data In Biotech, Ross Katz interviews Naren Tallapragada, CEO and Co-founder of Tessel Bio, about his background in electrical engineering and physics and how personal circumstances led to him pivoting his focus to enter biotech and start Tessel Bio.
Naren breaks down Tessel Bio’s unique approach to drug discovery, which involves "reverse engineering" chronic diseases. Instead of starting with a potential drug and testing its effects, they begin with a clear picture of the disease itself—specifically, how it appears and behaves in the body. A key part of their method is usin...
2025-03-0550 minData in BiotechHow Alex Junge from amass is Speeding Up Scientific Breakthroughs with AIIn this episode of the Data and Biotech Podcast, host Ross Katz sits down with Alexander Junge, Co-Founder and CTO of amass, to break down how AI is reshaping scientific research in life sciences.
Alex walks us through how his platform is creating professional tools for researchers, biotech companies, and venture firms to navigate the (rapidly!) growing breadth and depth of scientific knowledge by leveraging artificial intelligence - and what this will look like in the future.
Alex also shares insights into his company’s work with Nordic Bio Ventures and how amass delivers reliability and...
2025-02-1952 min
The Science MarketerB2B podcasting done right: A playbook for science marketersPodcasting has exploded in popularity across B2C industries, but in B2B marketing, its potential remains underutilized and misunderstood. Too often, companies launch a podcast, produce a handful of episodes, and then abandon it when the download numbers don’t skyrocket overnight.So, how can B2B companies, especially in niche industries like life sciences, make podcasting a powerful tool for thought leadership, relationship-building, and even lead generation?To answer that, I’m joined by Jason Bradwell, founder of B2B Better and a specialist in helping companies turn podcasts into a real business asse...
2025-02-1837 minData in BiotechAdvancing Therapeutic Design in Gene and Cell Therapy with Dipen SangurdekarIn this episode of Data in Biotech, Ross sits down with Dipen Sangurdekar, VP of Data Sciences at KSQ Therapeutics, to discuss the role of data-driven approaches in therapeutic design and development. The conversation explores the intersection of computational biology, machine learning, and bioinformatics in advancing personalized medicine and improving patient outcomes.
Dipen shares his journey in the industry, emphasizing the importance of integrating data science with biological research and the challenges associated with working in the rapidly evolving field of cell therapies. From hypothesis-driven research to leveraging multimodal data for actionable insights, this episode explores the...
2025-02-1040 minData in BiotechDemocratizing Therapeutic Discovery for Neglected Diseases using AI with Timothy Jenkins of DTU BioengineeringThis week on Data in Biotech, we welcome Timothy Jenkins, the Head of Data Science and Associate Professor at DTU Bioengineering, a leading scientific community dedicated to advancing areas of biotechnology, food technology, and health through innovative teaching and research.
Timothy starts the conversation by walking us through his background and early career beginnings, from the first time he expressed interest in zoology and venomous snakes to now leading a research group focused on AI-guided drug discovery for snake antivenom.
He and our host, Ross Katz, dive into one of DTU’s most exciting recent pub...
2025-01-2250 minData in BiotechRevolutionizing Drug Discovery with AI: Fred Manby of Iambic TherapeuticsIn this episode, Ross Katz sits down with Fred Manby, Co-Founder and Chief Technology Officer of Iambic Therapeutics, to explore how cutting-edge AI technologies are reshaping the landscape of drug discovery. From building advanced machine learning platforms to designing user-friendly interfaces for scientists, Fred shares insights into the company’s approach to tackling some of the biggest challenges in biotech.
Fred dives into the unique capabilities of Iambic’s Enchant multi-modal transformer model, its differentiation from other biological foundation models, and the importance of aligning model architecture with data creation and acquisition in modern drug discovery. We also...
2025-01-0838 minData in BiotechUnlocking the Power of AI in Microscopy with Ilya Goldberg and Reese FindleyIn this episode of Data in Biotech, Ross Katz explores the transformative role of AI in microscopic imaging and life sciences with Ilya Goldberg, Chief Science Officer, and Reese Findley, an AI Data Scientist at ViQi.
They discuss the cutting-edge applications of AI in automating high-content screening (HCS), enabling more efficient drug discovery, and unraveling complex biological processes. From streamlining time-course analysis to detecting off-target effects in drug compounds, ViQi’s tools are revolutionizing how scientists approach image-based data.
Key Highlights:
How AI-powered "eyes" analyze thousands of microscopy images to identify phenotypic cha...
2024-12-1147 minData in BiotechReflections & Predictions: One Year of Data in Biotech with Ross KatzIn this episode of Data in Biotech, Ross Katz reflects on what he’s learned from one year of hosting the podcast. Diving deep into the intersection of data science and biotechnology, this episode covers topics like:
The need for predictive models in biotech that are grounded in real-world experimentation.The challenges of biases in model evaluation and designing experiments that maximize collecting information for iterative improvements.The balance between leveraging computational methods and validating insights through experimental data.
As we look to 2025, Ross shares his vision of the emerging democratization of the biotech data ecosystem by mak...
2024-11-2739 min
The Ravit ShowWhy is Small Data important?Hear it from the best – James Winegar, CEO at CorrDyn, during the Small Data SF conference. We discussed about the use cases of small data, future of small data, why should you start focusing on small data and much more!
#data #ai #smalldatasf #theravitshow
2024-11-0707 minData in BiotechFrom Moderna to Dash Bio - Revolutionizing Drug Development with Dave JohnsonIn this episode of Data in Biotech, Ross Katz sits down with Dave Johnson, CEO and co-founder of Dash Bio, a next-gen drug development services company with a mission to revolutionize clinical bioanalysis and streamline drug development.
Dave begins the episode by taking us back to the early research days in Moderna, where he helped lay the groundwork for mRNA technology, which later enabled the development of a vaccine for COVID-19 at unprecedented speed. As he explains, this automated work and pre-built systems ultimately played a central role in responding to urgent health challenges.
He...
2024-10-3032 minData in BiotechChitrang Dave on Harnessing Real-Time Data to Transform MedTech and HealthcareThis week, Chitrang Dave, Global Head of Enterprise Data & Analytics at Edwards Lifesciences, joins us to discuss the transformative power of real-time data, AI, and collaboration in medical device manufacturing and support.
He and host, Ross Katz, dive into how real-time data from IoT devices is reshaping quality assurance in medtech and what the future holds for medtech as big tech players like Apple and Meta enter the healthcare arena.
Together, they discuss everything from AI-powered patient identification to the integration of consumer wearables with FDA-approved medical devices. Tune in to hear how collaboration, innovation, an...
2024-10-1629 minData in BiotechChitrang Dave on Harnessing Real-Time Data to Transform MedTech and HealthcareThis week, Chitrang Dave, Global Head of Enterprise Data & Analytics at Edwards Lifesciences, joins us to discuss the transformative power of real-time data, AI, and collaboration in medical device manufacturing and support.
He and host, Ross Katz, dive into how real-time data from IoT devices is reshaping quality assurance in medtech and what the future holds for medtech as big tech players like Apple and Meta enter the healthcare arena.
Together, they discuss everything from AI-powered patient identification to the integration of consumer wearables with FDA-approved medical devices. Tune in to hear how collaboration, innovation, an...
2024-10-1625 minData in BiotechAutomating Bioprocessing to Speed up Workflows with InvertThis week on Data in Biotech, we’re joined by Martin Permin, the co-founder of Invert, a company that builds software that automates bioprocessing.
Martin talks us through his own unique journey into biotech - starting from a role at Airbnb - through to co-founding Invert. Invert helps users grab data from their instruments, map out their individual processes, clean up the data for analysis, and look for ways to speed up the “mundane” data cleaning tasks that often take up the majority of one’s time.
With our host, Ross Katz, Martin tells us the stati...
2024-10-0236 minData in BiotechThe Evolution of Genomic Analysis with SapientThis week on Data in Biotech, we’re joined by Mo Jain, the Founder and CEO of Sapient, a biomarker discovery organization that enables biopharma sponsors to go beyond the genome to accelerate precision drug development.
Mo talks us through his personal journey into the world of science, from school to working in academia to founding his business, Sapient.
He explains how and why Sapient first started and the evolution of the high-throughput mass-spectrometry service it provides to the biopharmaceutical sector.
Together with our host Ross, they explore the technology that’s allowed scient...
2024-09-1843 minData in BiotechTransforming Drug Discovery through AI and Single-Cell Multiomics with CellarityThis week on Data in Biotech, we are joined by Parul Bordia Doshi, Chief Data Officer at Cellarity, a company that is leveraging data science to challenge traditional approaches to drug discovery.
Parul kicks off the conversation by explaining Cellarity’s mission and how it is using generative AI and single-cell multiomics to design therapies that target the entire cellular system, rather than focusing on single molecular targets.
She gives insight into the functionality of Cellarity Maps, the company’s cutting-edge visualization tool that maps the progression of disease states and bridges the gap between biolo...
2024-08-2839 minData in BiotechUsing Generative AI to Design New Therapeutic Proteins with EvozyneThis week on Data in Biotech, Ryan Mork, Director of Data Science at Evozyne, joins host Ross Katz to discuss how data science and machine learning are being used in protein engineering and drug discovery.
Ryan explains how Evozyne is utilizing large language models (LLMs) and generative AI (GenAI) to design new biomolecules, training the models with huge volumes of protein and biology data. He walks through the organization’s evolution-based design approach and how it leverages the evolutionary history of protein families.
Ross and Ryan dig into the different models being used by Evozyne, in...
2024-08-1440 minData in BiotechBalancing Software-Driven Processes and Human Curation to Unlock Genomics Intelligence with GenomenonThis week on Data in Biotech, Ross is joined by Jonathan Eads, VP of Engineering at genomics intelligence company Genomenon, to discuss how his work supports the company’s mission to make genomic evidence actionable.
Jonathan explains his current role leading the teams focused on clinical engineering, curation engineering, platform development and overseeing Genomenon’s data science and AI efforts.
He gives insight into how Genomenon’s software works to scan genomics literature and index genetic variants, providing critical evidence-based guidance for those working across biotech, pharmaceutical, and medical disciplines.
Jonathan outlines the issues...
2024-07-3140 minData in BiotechOptimizing Allogeneic Cell Therapy Manufacturing with Atara BiotherapeuticsThis week on Data in Biotech, we’re joined by Amy Gamber, VP of Manufacturing at Atara Biotherapeutics, an allogeneic T-cell immunotherapy company developing off-the-shelf treatments to help achieve faster patient outcomes.
As a treatment that sits at the cutting edge of options available for cancer and autoimmune disease, host Ross Katz explores how Atara is able to deliver personalized medicine that can be with the patient inside a three-day window.
Amy is clear-eyed about what works well in this field and what doesn’t. We gain insight into the complexity of developing this type of cel...
2024-07-1740 minData in BiotechA Look Back on Design of ExperimentsIt's a holiday week here in the U.S., and the CorrDyn team is currently getting together for our annual company retreat. So, we decided to do something a little different this week.
We're re-releasing abridged versions of two of our most popular episodes.
These are dedicated to a critical workflow at the intersection of data and scientific research - Design of Experiments.
Across these interviews, we brought together two leading experts to give you a comprehensive overview of how best-practice DOE works in the biotech industry - Wolfgang Halter from Merck Life...
2024-07-0355 minData in BiotechGiving Biotech Organizations a ‘Digital Brain’ with ScispotThis week on Data in Biotech, we’re delighted to be joined by Guru and Satya Singh, co-founders of SciSpot, a company focused on transforming biotech companies through smarter embodiment of biological processes in data/software and acceleration of the R&D process.
They discuss how their respective biotech and data backgrounds led them to develop the platform and their very personal motivation behind their mission to enable data to accelerate life science research.
Guru and Satya explore the concept of giving biotech companies a “digital brain” that uses AI to learn from every experiment. They e...
2024-06-1936 minData in BiotechDelivering AI-Driven Drug Development with Generate:BiomedicinesThis week, Ross sits down with Mike Nally, CEO at Generate:Biomedicines, a pioneer in generative biology that is transforming the way medicines are developed. Mike joined the Data in Biotech podcast to discuss the AI-driven drug development landscape and how data is set to change the way every drug is made in the future.
Mike shares his journey to Generate:Biomedicines, motivated by the ambition to improve productivity and democratize the availability of drugs.
He discusses the latest in drug development trends, from how the availability of data accelerates what is possible to breakthroughs...
2024-06-0537 minData in BiotechSolving Data Integration Challenges in Life Sciences with GanymedeThis week, Nathan Clark, CEO at Ganymede, joins the Data in Biotech podcast to discuss the challenges of integrating lab instruments and data in the biotech industry and how Ganymede’s developer platform is helping to automate data integration and metadata management across Life Sciences.
Nathan sits down with Data in Biotech host Ross Katz to discuss the multiple factors that add to the complexity of handling lab data, from the evolutionary nature of biology to the lab instruments being used. Nathan explains the importance of collecting metadata as unique identifiers that are essential to facilitating automation an...
2024-05-2244 minData in BiotechThe Power of Open-Source Pipelines for Scientific Research with Harshil PatelThis week, Harshil Patel, Director of Scientific Development at Seqera, joins the Data in Biotech podcast to discuss the importance of collaborative, open-source projects in scientific research and how they support the need for reproducibility.
Harshil lifts the lid on how Nextflow has become a leading open-source workflow management tool for scientists and the benefits of using an open-source model. He talks in detail about the development of Nextflow and the wider Seqera ecosystem, the vision behind it, and the advantages and challenges of this approach to tooling.
He discusses how the nf-core community collaboratively...
2024-05-0841 minData in BiotechImprove Quality and Minimize Variability in Biotech Manufacturing with Stewart FosscecoThis week, we are pleased to have Stewart Fossceco, Head of Non-Clinical and Diagnostics Statistics at Zoetis and an expert in pharmaceutical manufacturing, join us on the Data in Biotech podcast.
We sat down with Stewart to discuss implementing and improving Quality Assurance (QA) processes at every stage of biotech manufacturing, from optimizing assay design and minimizing variability in early drug development to scaling this up when moving to full production. Stewart talks from his experiences on the importance of experimental design, understanding variability data to inform business decisions, and the pitfalls of over measuring.
A...
2024-04-2438 minData in BiotechDelivering on the Promise of Electronic Lab Notebooks with SciNoteThis week, we are pleased to welcome to the Data in Biotech podcast Brendan McCorkle, CEO of SciNote, a cloud-based ELN (Electronic Lab Notebook) with lab inventory, compliance, and team management tools.
In this episode, we discuss how the priorities of ‘Research’ and ‘Development’ differ when it comes to the data they expect and how they use it, and how ELNs can work to support both functions by balancing structure and flexibility. We explore the challenges of developing an ELN that serves the needs and workflows of all stakeholders, making the wider business case for ELNs, and why, in...
2024-04-1043 minData in BiotechDeveloping Future Sustainable Materials Using AI with CambriumThis week, we are pleased to be joined on the Data in Biotech Podcast by Pierre Salvy, who recently became the CTO at Cambrium, and his colleague Lucile Bonnin, Head of Research & Development at Cambrium.
As part of the Cambrium team behind NovaColl™, the first micro-molecular and skin-identical vegan collagen to market, Pierre and Lucile share their practical experiences of using AI to support protein design.
We ask why Cambrium, as a molecular design organization, decided to focus on the cosmetics industry and dig into the factors that have driven its success. From developing a pro...
2024-03-2739 minData in BiotechBuilding Strong Data Foundations for Biotech Startups with Jacob OppenheimThis week, we are pleased to welcome Jacob Oppenheim, Entrepreneur in Residence at Digitalis Ventures, a venture capital firm that invests in solutions to complex problems in human and animal health.
Jacob sat down with Ross to discuss the importance of establishing strong data foundations in biotech companies and how to approach the task. We explore the challenges biotech organisations face with existing tools. What are the limitations, and why are current data tools and systems not yet geared toward helping scientists themselves extract meaningful insights from the data?
We also get Jacob’s take on...
2024-03-1342 minData in BiotechHow OmicSoft Is Facilitating In-Depth Exploration Among NGS DatasetsThis week's guest is Joseph Pearson, Global Product Manager of OmicSoft at QIAGEN, a global provider of sample-to-insight solutions that enable customers to gain valuable molecular insights.
During this episode, we dive into OmicSoft, a powerful NGS analysis suite that can quickly explore and compare 500,000 curated omics samples from disease-related studies. Joseph outlines the challenges of acquiring and analysing NGS data sets, how customers can interact with OmicSoft data, and what he thinks of the build versus buy debate when selecting new bioinformatics tools.
Data in Biotech is a fortnightly podcast exploring how companies leverage da...
2024-02-2834 minData in BiotechHow Bayesian Optimization is Helping to Accelerate Innovation at Merck GroupThis week's guest is Wolfgang Halter, Head of Data Science and Bioinformatics at Merck Life Science, a leading global science and technology company.
Ross sat down with Wolfgang to discuss the work on the BayBE project, an open-source library built for Bayesian optimization. Throughout the episode, we go on to learn how BayBE is used for both experimental design and as a means to accelerate innovation. The pair also discusses the benefits and challenges of Bayesian optimization and the need for standardised data models. Finally, Wolfgang shares some advice for those scientists and engineers who are keen t...
2024-02-1439 minData in BiotechTransforming Care for Neurological Disorders Through Artificial Intelligence with Annemie RibbensThis week, we’re delighted to be joined by Annemie Ribbens, VP Science, Evidence and Trials at icometrix, a medical technology manufacturer that offers a portfolio of AI solutions to assist healthcare with various challenges in neurological disorders, such as brain trauma, strokes, dementia, and Alzheimer's disease.
During this episode, Annemie opens up on icometrix’s mission in analyzing and treating neurological disorders, the work that went into developing the data infrastructure and the challenges they face when dealing with such large data sets. Annemie also goes on to discuss how machine learning will influence the application of pr...
2024-01-3148 minData in BiotechThe Applications of Real-World Data in Biotech with Lana DenysykThis week, we’re delighted to be joined by Lana Denysyk, Head of RWD Assets at Novo Nordisk.
During this conversation, Lana shares how real-world data is used in biotech, diving into how it can help clinicians understand patient experiences outside clinical trials. Lana also discusses the challenges in acquiring and utilising real-world data, the importance of having a centralised team to manage it, and emerging data types like patient-reported outcomes and health equity data.
Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences.
Discussed: ...
2024-01-1734 minData in BiotechThe Role of Knowledge Graphs in Biopharma with Cody SchifferThis week, we’re delighted to be joined by Cody Schiffer, Associate Director, Machine Learning at SMPA - a biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need,
During this conversation, Cody and Ross discuss the construction, maintenance, and application of a knowledge graphic in biopharma, including how to integrate structured and unstructured data to support tasks like literature searches, competitive intelligence and drug discovery and the challenges in keeping a knowledge graph updated with new, real-time information.
Data in Biotech is a fortnightly podcast exploring how companies leverage data...
2024-01-0341 minData in BiotechOvercoming Data Fragmentation in Healthcare with Vera MucajThis week, we’re delighted to be joined by Vera Mucaj, Chief Scientific Officer at Datavant, a data logistics company for healthcare.
During the interview, Vera shares how the organization helps companies overcome issues of data fragmentation and availability, which ultimately leads to better decision-making in healthcare, the importance of connecting clinical trial data with real-world data to improve research outcomes and the challenges of semantic interoperability in data sets.
Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences.
Discussed:
[1:06] Ve...
2023-12-2045 minData in BiotechMachine Learning and Quality Control in Biotech Manufacturing with James WinegarData in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences.
This week, we’re delighted to be joined by James Winegar, CEO of CorrDyn, a data-driven technology consultancy that helps some of the largest biotechnology manufacturers in the US make smarter strategic decisions by unlocking the value of their data.
In this conversation, James and Ross discuss the application of machine learning in biotech manufacturing quality control, their work in providing a custom oligo manufacturer with a data analysis system to track whether certain manufacturing events are anomalous or pa...
2023-12-0629 minData in BiotechSolving Reproducibility Challenges in Biotech with Harry RickerbyData in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences.
This week, we’re delighted to be joined by Harry Rickerby, Co-founder of Briefly Bio, a groundbreaking platform he's developing to streamline experimental design in life sciences using large language models (LLMs).
Host Ross Katz speaks with Harry about how LLMs are used to facilitate experiment protocol structuring in the platform, the limitations of LLMs in scientific fields, how we can improve collaboration, consistency, and reproducibility in biotech, and how metadata is generated within the experimental design process while int...
2023-11-2241 minData in BiotechJesse Johnson on Bridging the Data Gap in Biotech StartupsData in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences.
This week, we’re delighted to be joined by Jesse Johnson, Founder of Merelogic, a consultancy service for biotech startups who want to get their data under control so they can focus on the science.
Host Ross Katz speaks with Jesse about the importance of data in biotech startups, the challenges of bridging the gap between biologists and data scientists, the need for more modular and customizable data tools, and the potential for automation and AI in biotech research....
2023-11-0842 minData in BiotechTommy Tang on Building a Dry Lab Team, Selecting the Right Tools, and When to Use ML in BioinformaticsData in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences.
This week, we're delighted to be joined by Tommy Tang, Director of Computational Biology at Immunitas Therapeutics - an immuno-oncology therapeutics company advancing multiple programs to the clinic.
Host Ross Katz speaks with Ming “Tommy” Tang about the scalability of the cloud and its impact on improving biotech data, Keeping data in-house vs. big data warehouses (and the messiness of public data), where ML should best play in computational biology and so much more.
---
...
2023-10-2545 minData in BiotechThe Future of Clinical Trials: How Data, AI and ML Will Improve Healthcare with Miguel Cacho SoblecheroData in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences.
This week, we're delighted to be joined by Miguel Cacho Soblechero, Ph.D., a senior data scientist at Prolaio - a biotech company that integrates clinical research and data science to improve research, access and outcomes for people with heart conditions.
Host Ross Katz speaks with Miguel on the lessons learned transitioning from a Ph.D. into the data science industry of biotechnology, the problems with the current state of data in clinical trials, and the massive o...
2023-10-1136 minData in BiotechFighting Cancer with Data Science and CAR-T Therapies with Pradeep RavindraThis week we’re excited to be joined by Pradeep Ravindra, Associate Director, Data Analytics, Manufacturing from Lyell Immunopharma.
He shares his story on transitioning from military intelligence to life sciences analytics, the role of data analytics in manufacturing and delivering CAR-T therapies, and how to foster a culture of data-driven decision-making and collaboration within a biotech organization.
---
If you’re a biotech company struggling to transform your business with data, CorrDyn can help.
Whether you need to supplement existing technology teams with specialist expertise or launch a data program that...
2023-09-2639 minData in BiotechWelcome to Data in Biotech - a CorrDyn PodcastWelcome to Data in Biotech, a podcast from CorrDyn where we explore how companies leverage data to drive innovation in life sciences.
In each episode, our host Ross Katz, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in life sciences.
2023-09-2500 min